Search

Your search keyword '"Chen, Jinjun"' showing total 25 results

Search Constraints

Start Over You searched for: Author "Chen, Jinjun" Remove constraint Author: "Chen, Jinjun" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years Journal journal of hepatology Remove constraint Journal: journal of hepatology
25 results on '"Chen, Jinjun"'

Search Results

1. Metabolic biomarkers significantly enhance the prediction of HBV-related ACLF occurrence and outcomes

2. Baveno VII algorithm outperformed other models in ruling out high-risk varices in individuals with HBV-related cirrhosis

3. SAT-068 Accuracy of spleen stiffness measurement for the diagnosis of high-risk esophageal varices in patients with advanced chronic liver disease: a systematic review and individual patient data meta-analysis

4. LBP-045 Efficacy and safety of HSK31679, a thyroid hormone receptor β agonist, for the treatment of asian non-alcoholic fatty liver disease: a multicenter randomized, double-blind, placebo-controlled, phase 2a trial

5. SAT-198 ASC41, a selective THRβ agonist significantly reduces liver fat and ALT in biopsy-confirmed MASH patients after 12-week treatment: an interim analysis of a 52-week serial liver biopsy study

6. LBP-037 Role of early on-treatment serum hepatitis B virus RNA declines in the prediction of hepatocellular carcinoma risk in patients with chronic hepatitis B

11. Metabolic biomarkers significantly enhance the prediction of HBV-related acute-on-chronic liver failure prognosis

12. Nosocomial infections in cirrhosis are unpredictable and vary based on region of the world: CLEARED study

14. Prognostic and therapeutic significance of microbial cell-free DNA in plasma of people with acute decompensation of cirrhosis

15. LEARN algorithm: a novel option for predicting non-alcoholic steatohepatitis

16. Impact of predisposition and precipitants on the short-term prognosis among inpatients with chronic liver disease

17. Safety, pharmacokinetics and efficacy of the novel pan-phosphodiesterase inhibitor ZSP1601 in 36 NASH patients: a double-blinded, placebo-controlled, multiple-dose escalation phase Ib study

18. FRI-053 Wide variations in proton pump inhibitor use in hospitalized patients with cirrhosis in a worldwide cohort shows little impact on clinically significant outcomes

22. FRI-546 - Nosocomial infections in cirrhosis are unpredictable and vary based on region of the world: CLEARED study

Catalog

Books, media, physical & digital resources